Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bonviva Plus for TSH suppression-induced bone loss in postmenopausal differentiated thyroid cancer patients
KCT0006546Phase 3Active, not recruiting
- Sponsor
- Handok
- Start
- Feb 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibandronate, vitamin d, calcium carbonate in low bone mineral density, osteoporosis, sponsored by Handok. Started Feb 2020; status: active, not recruiting.
02
Drugs
ibandronatevitamin dcalcium carbonate
03
Conditions
low bone mineral densityosteoporosis
Beyond the preview
Go deeper on KCT0006546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006546.